Showing results for: "molecule reimagining" (24 results)
Disorders of Gut–Brain Interaction (DGBIs), such as Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS), present a formidable clinical impasse due to their profoundly heterogeneous and multifactorial nature.
Ever wonder what it’s like if a tiny chip could detect cancer before symptoms appear. Biosensor technology is transforming cancer detection- earlier, faster and more accessible for people worldwide
Selective oxidation reactions are central to modern biochemistry. They enable the controlled introduction of oxygen into organic molecules, a key step in the synthesis of pharmaceuticals and fine chemicals. However, many of the enzymatic systems traditionally used for these transformations are complex and difficult to implement in practice.
How a 150-year-old food industry technique became essential for creating stable biologics and inhaled medicines, transforming liquid drugs into life-saving powders.
Antibiotic resistance could kill 10 million annually by 2050. Discover how AI found Halicin, a molecule that kills superbugs humans couldn't defeat.
Scientists are closer than ever to detecting life beyond Earth. From Mars to distant exoplanets, modern astronomy is transforming the search for alien life.
Tuberculosis (TB) remains one of the world's deadliest infectious diseases, claiming over a million lives each year. TB is the deadliest infectious disease known today, claiming more lives than COVID-19. TB is caused by the bacterium Mycobacterium tuberculosis. TB spreads through the air when infected people breathe, cough, sneeze,
This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.
Alzheimer’s is a progressive neurological disorder with classic clinical symptoms such as dementia, cognitive decline, and behavioural changes, particularly in the ageing population.
Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.
Discover how the SNAP29 gene guides cellular traffic, and how its mutation leads to CEDNIK syndrome, affecting brain, nerves, and skin.
Self-healing materials (SHMs) are substances that automatically repair damage, mimicking organic healing. These materials have a wide range of applications, including construction, biomedicine, transportation, and even textiles. SHMs can extend the longevity of manufactured goods and have numerous uses in medical healing (Crawford, 2024).
ears pass in schoolrooms where future doctors study life's inner workings, cells, chemicals, and body parts. From books they recall illness patterns, how molecules bond, ways to spot health troubles
Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.
Learn how the leading cause of death worldwide activates the immune system and how making a few lifestyle changes can decrease your risk of severe chronic disease.
Cells constantly sense signals from their environment and convert them into internal actions through biochemical signalling pathways.
The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,
This article aims to demystify the anatomy of a clinical trial protocol, peeling back the technical layers to reveal how scientific rigor is converted into medical progress. At ScientistsHub, we often ask: How do we ensure that a medical breakthrough is not just a stroke of luck, but a repeatable, verifiable victory for human health? The answer is found in the design. To truly appreciate the result of any trial, one must first master the architecture of the inquiry.
Messenger RNA (mRNA) vaccines represent one of the most significant scientific advances in modern therapeutics. Unlike conventional vaccines that use weakened or inactivated pathogens, mRNA vaccines deliver genetic instructions that enable host cells to synthesize a target antigen and stimulate an immune response.
Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.
